"Caspase Inhibitors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous and exogenous compounds and that either inhibit CASPASES or prevent their activation.
| Descriptor ID |
D061945
|
| MeSH Number(s) |
D27.505.519.389.745.325.500
|
| Concept/Terms |
Caspase Activation Inhibitors- Caspase Activation Inhibitors
- Activation Inhibitors, Caspase
- Inhibitors, Caspase Activation
- Caspase Activation Blockers
- Activation Blockers, Caspase
- Blockers, Caspase Activation
- Capase Activation Inhibitors
- Activation Inhibitors, Capase
- Inhibitors, Capase Activation
|
Below are MeSH descriptors whose meaning is more general than "Caspase Inhibitors".
Below are MeSH descriptors whose meaning is more specific than "Caspase Inhibitors".
This graph shows the total number of publications written about "Caspase Inhibitors" by people in this website by year, and whether "Caspase Inhibitors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 1999 | 1 | 2 | 3 |
| 2000 | 1 | 1 | 2 |
| 2001 | 0 | 5 | 5 |
| 2002 | 1 | 6 | 7 |
| 2003 | 5 | 3 | 8 |
| 2004 | 1 | 5 | 6 |
| 2005 | 2 | 7 | 9 |
| 2006 | 0 | 3 | 3 |
| 2007 | 1 | 4 | 5 |
| 2008 | 1 | 2 | 3 |
| 2009 | 0 | 2 | 2 |
| 2010 | 0 | 4 | 4 |
| 2011 | 1 | 1 | 2 |
| 2012 | 0 | 2 | 2 |
| 2014 | 0 | 1 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 0 | 1 | 1 |
| 2018 | 1 | 0 | 1 |
| 2020 | 0 | 1 | 1 |
| 2022 | 0 | 1 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Caspase Inhibitors" by people in Profiles.
-
Cellular autophagy, an unbidden effect of caspase inhibition by zVAD-fmk. FEBS J. 2022 06; 289(11):3097-3100.
-
Caspase-8 loss radiosensitizes head and neck squamous cell carcinoma to SMAC mimetic-induced necroptosis. JCI Insight. 2020 12 03; 5(23).
-
Emricasan Improves Liver Function in Patients With Cirrhosis and High Model for End-Stage Liver Disease Scores Compared With Placebo. Clin Gastroenterol Hepatol. 2019 03; 17(4):774-783.e4.
-
Trimethylamine-N-Oxide Instigates NLRP3 Inflammasome Activation and Endothelial Dysfunction. Cell Physiol Biochem. 2017; 44(1):152-162.
-
Activation of NLRP3 inflammasomes in mouse hepatic stellate cells during Schistosoma J. infection. Oncotarget. 2016 Jun 28; 7(26):39316-39331.
-
Endothelial NLRP3 inflammasome activation and enhanced neointima formation in mice by adipokine visfatin. Am J Pathol. 2014 May; 184(5):1617-28.
-
PARP1 during embryo implantation and its upregulation by oestradiol in mice. Reproduction. 2014 Jun; 147(6):765-80.
-
Blebbishields, the emergency program for cancer stem cells: sphere formation and tumorigenesis after apoptosis. Cell Death Differ. 2013 Mar; 20(3):382-95.
-
TRAIL induces autophagic protein cleavage through caspase activation in melanoma cell lines under arginine deprivation. Mol Cell Biochem. 2013 Feb; 374(1-2):181-90.
-
Hypoxia/reoxygenation impairs memory formation via adenosine-dependent activation of caspase 1. J Neurosci. 2012 Oct 03; 32(40):13945-55.